08048035968
ASPADOL ER 150MG Tablets  wholesale and global supplier from India to Australia | Phoenix Exim.

1. General Information

ASPADOL ER 150MG Tablets are extended-release pain-relieving tablets containing tapentadol 150 mg. Tapentadol is an opioid analgesic with additional noradrenaline reuptake-inhibiting activity. Extended-release tapentadol is intended for adults who require ongoing opioid analgesia for severe and persistent pain when alternative treatments are inadequate.

Phoenix Exim is a pharmaceutical exporter from Nagpur, India, serving international markets including the USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable pharmaceutical import, prescription, and controlled-substance regulations.

2. Product Information

  • Product: ASPADOL ER 150MG Tablets
  • Active ingredient: Tapentadol
  • Strength: 150 mg
  • Dosage form: Extended-release tablet
  • Route: Oral
  • Therapeutic category: Opioid analgesic
  • Purpose: Management of severe and persistent pain requiring prolonged opioid treatment
  • Prescription status: Prescription/controlled medicine depending on the country

Tapentadol extended-release tablets are available in strengths including 50 mg, 100 mg, 150 mg, 200 mg and 250 mg in U.S. prescribing information.

3. Uses of ASPADOL ER 150MG

Tapentadol extended-release may be prescribed for:

  • Severe and persistent chronic pain requiring long-term opioid analgesia.
  • Certain severe neuropathic pain conditions, including neuropathic pain associated with diabetic peripheral neuropathy, where indicated.
  • Pain where other appropriate treatment options have not provided adequate relief.

It should not be used simply for occasional or mild pain unless specifically prescribed by a healthcare professional.

4. Benefits

When appropriately prescribed, potential benefits include:

  • Helps provide prolonged pain relief.
  • Can reduce the intensity of severe persistent pain.
  • May help improve daily functioning when pain is adequately controlled.
  • Its dual mechanism provides both opioid activity and noradrenaline reuptake inhibition, which contributes to its analgesic effect.

Because it is an extended-release opioid, treatment should be individualized and regularly reassessed.

5. Side Effects

Tapentadol ER can cause serious adverse effects. Important risks include:

  • Respiratory depression
  • Excessive sedation
  • Opioid dependence, abuse or misuse
  • Overdose
  • Severe hypotension
  • Serotonin syndrome with certain interacting medicines
  • Seizures in susceptible individuals
  • Withdrawal symptoms after abrupt discontinuation
  • Opioid-induced hyperalgesia in some patients

Seek urgent medical attention for severe difficulty breathing, extreme sleepiness, loss of consciousness, severe confusion, seizure, or suspected overdose.

6. Common Side Effects

Commonly reported adverse reactions to tapentadol extended-release include:

  • Nausea
  • Constipation
  • Dizziness
  • Headache
  • Somnolence/drowsiness

Other effects can occur depending on the individual, dose, other medicines, and underlying health conditions.

7. How to Use

ASPADOL ER 150MG should be taken exactly as prescribed by a qualified healthcare professional.

  • Take the tablet orally according to the prescribed schedule.
  • Swallow the extended-release tablet whole.
  • Do not crush, chew, dissolve, or break it unless the product-specific prescribing information expressly permits this.
  • Do not increase the dose or frequency without medical advice.
  • Do not stop long-term treatment suddenly because withdrawal and uncontrolled pain can occur.

Because the appropriate dose varies substantially between patients, the 150 mg strength should not be treated as a universally appropriate starting dose.

8. How This Medicine Works

Tapentadol has two main analgesic actions:

  1. It activates mu-opioid receptors, reducing the transmission and perception of pain.
  2. It inhibits noradrenaline reuptake, increasing noradrenergic activity involved in the body's pain-control pathways.

Together, these mechanisms provide analgesic activity for appropriate patients with severe persistent pain.

9. Safety Advice

  • Use only with a valid prescription and medical supervision.
  • Do not combine with alcohol unless your doctor specifically advises otherwise.
  • Tell your doctor about all medicines you take, particularly sedatives, benzodiazepines, antidepressants, other opioids, and serotonergic medicines.
  • Do not drive or operate machinery until you know how the medicine affects you.
  • Tapentadol ER is contraindicated in significant respiratory depression, certain severe asthma situations, gastrointestinal obstruction/paralytic ileus, hypersensitivity to tapentadol, and concurrent MAOI use or MAOI use within the preceding 14 days.
  • Extra caution is required in people with respiratory disease, seizure disorders, head injury, liver or kidney impairment, or conditions associated with low blood pressure.
  • Pregnancy and breastfeeding require specific medical assessment; current U.S. prescribing information advises that it may cause fetal harm and is not recommended during lactation.
  • Never share this medicine with another person.

10. FAQs

Q1. What is ASPADOL ER 150MG used for?
It is an extended-release tapentadol formulation used under medical supervision for severe and persistent pain requiring ongoing opioid analgesia.

Q2. Is ASPADOL ER 150MG an opioid?
Yes. Tapentadol is an opioid analgesic and therefore carries risks of misuse, dependence, overdose, and respiratory depression.

Q3. Can ASPADOL ER 150MG be used for mild pain?
It is generally reserved for severe persistent pain when other appropriate treatment options are inadequate.

Q4. Can I crush or chew the tablet?
No. Extended-release tapentadol tablets should be swallowed whole because manipulating them can cause rapid release and potentially dangerous exposure.

Q5. Can I stop ASPADOL ER suddenly?
No, particularly after regular use. A healthcare professional should normally guide gradual dose reduction to reduce withdrawal risk.

Q6. Can ASPADOL ER cause drowsiness?
Yes. Somnolence is among the commonly reported adverse reactions.

Q7. Can it be taken with other medicines?
Some combinations can be dangerous. Always provide your doctor or pharmacist with a complete list of medicines and supplements before treatment.

11. Substitute for ASPADOL ER 150MG

A suitable substitute should not be selected solely by matching the strength. Depending on the diagnosis, treatment goals, and local availability, a physician may consider another tapentadol formulation or a different analgesic.

Potential alternatives may include other prescribed opioid or non-opioid analgesics, but the appropriate choice depends on the patient's condition, previous opioid exposure, other medicines, and risk factors. Tapentadol ER should not be automatically substituted on a milligram-for-milligram basis with another opioid.

12. SEO Keywords

Primary keywords:

  • ASPADOL ER 150MG Tablets
  • ASPADOL ER 150MG
  • ASPADOL ER 150 mg exporter
  • ASPADOL ER 150MG supplier
  • ASPADOL ER 150MG pharmaceutical exporter
  • Tapentadol 150MG ER Tablets
  • Tapentadol extended-release tablets
  • Tapentadol 150MG supplier India
  • Tapentadol ER medicine exporter
  • Tapentadol 150MG pharmaceutical supplier

Long-tail B2B keywords:

  • ASPADOL ER 150MG Tablets exporter from India
  • ASPADOL ER 150MG pharmaceutical supplier from Nagpur India
  • Tapentadol 150MG ER Tablets exporter from India
  • Tapentadol extended-release medicine supplier India
  • ASPADOL ER 150MG wholesale pharmaceutical supplier
  • Tapentadol 150MG medicine exporter to USA
  • Tapentadol 150MG medicine exporter to UK
  • Tapentadol 150MG medicine exporter to Australia
  • Tapentadol 150MG medicine exporter to Singapore
  • Tapentadol 150MG medicine exporter to Canada
  • Tapentadol 150MG medicine exporter to South Korea
  • Tapentadol 150MG medicine exporter to UAE
  • genuine pharmaceutical products supplier from India
  • prescription medicine exporter from Nagpur India
  • international pharmaceutical exporter Nagpur India
Aug 22nd, 2026 2:31 PM

Keywords